MapLight Therapeutics MPLT
NASDAQ MPLT
$7.48 +0.04 (+0.54%)
At close: Nov 11, 2026 · 4:00 PM EST

MapLight Therapeutics (MPLT) Other Accumulated Expenses (2024 - 2026)

Updated

MapLight Therapeutics' Other Accumulated Expenses was $1.14 million in Q2 2026.

Analysis

MapLight Therapeutics (MPLT) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at MapLight Therapeutics came in at $521,000, down 66.6% from FY2024.

  • In earlier years, Other Accumulated Expenses was $1.56 million in FY2024.
  • Quarterly Other Accumulated Expenses has moved between $521,000 (Q4 2025) and $2.13 million (Q3 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 MapLight Therapeutics 338.05 Mn 33.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.14 Mn
Mar 31, 2026 677,000.00
Dec 31, 2025 521,000.00
Sep 30, 2025 2.13 Mn
Dec 31, 2024 1.56 Mn
API Access

MapLight Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MPLT&period=max&api_key=YOUR_API_KEY